Quantification of chondroitin sulfate and dermatan sulfate in danaparoid sodium by 1H NMR spectroscopy and PLS regression

Analytical and Bioanalytical Chemistry

Volumn 399, Issue 2, 2011, Pages 629-634

  Ustun B ^a   Sanders, K B ^a   Dani, P ^a   Kellenbach, E R ^a  

^a NV ORGANON   (Netherlands)

Author keywords

1H NMR spectroscopy; Chemometrics; Chondroitin sulfate; Danaparoid sodium; Dermatan sulfate; Glycosaminoglycans; Heparan sulfate; Partial least squares regression

Indexed keywords

CHEMOMETRICS; CHONDROITIN SULFATE; DANAPAROID SODIUM; DERMATAN SULFATE; GLYCOSAMINOGLYCANS; H NMR SPECTROSCOPY; HEPARAN SULFATES; PARTIAL LEAST-SQUARES REGRESSION;

DISEASES; DRUG PRODUCTS; HIP PROSTHESES; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; REGRESSION ANALYSIS; SODIUM; SPECTRUM ANALYSIS;

SODIUM SULFATE;

ANTICOAGULANT AGENT; CHONDROITIN SULFATE; DANAPAROID; DERMATAN SULFATE; HEPARAN SULFATE;

ARTICLE; CHEMISTRY; EVALUATION; METHODOLOGY; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

ANTICOAGULANTS; CHONDROITIN SULFATES; DERMATAN SULFATE; HEPARITIN SULFATE; MAGNETIC RESONANCE SPECTROSCOPY; MULTIVARIATE ANALYSIS;

EID: 79251564931     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-010-4193-7     Document Type: Article

References (15)

1. Acostamadiedo JM, Uma G, Owen J, Ahley Publications Ltd (2000) ISSN 1465-6566
2. MT Nurmohamed H ten Cate JW ten Cate 1997 Low molecular weight heparin(oid)s Drugs 53 5 736 751 1:CAS:528:DyaK2sXjtFOjs7Y%3D 10.2165/00003495-199753050-00002
3. VA Skoutakis 1997 Danaparoid in the prevention of thromboembolic complications Ann Pharmacol 31 876 887 1:CAS:528:DyaK2sXkvVCktLo%3D
4. European Pharmacopoeia 6.0, pp. 1644-1646
5. W Huang W Luin Y Li S Suzuki N Sugiura H Miyazono M Cygler 2003 Crystal structure of Proteus vulgaris chondroitin sulfate ABC lyase I at 1.9∈Å resolution J Mol Biol 328 3 623 634 1:CAS:528: DC%2BD3sXjtFeru7Y%3D 10.1016/S0022-2836(03)00345-0
6. J Féthière B Eggimann M Cygler 1999 Crystal structure of chondroitin AC lyase, a representative of a family of glycosaminoglycan degrading enzymes J Mol Biol 288 4 635 647 10.1006/jmbi.1999.2698
7. T Beyer B Diehl G Randel E Humpfer H Schäfer M Spraul C Shollemayer U Holzgrabe 2008 Quality assessment of unfractionated heparin using 1H nuclear magnetic resonance spectroscopy J Pharm Biomed Anal 48 13 19 1:CAS:528:DC%2BD1cXhtVartrfK 10.1016/j.jpba.2008.06.014
8. M Guerrini 2008 Oversulphated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events Nat Biotechnol 26 669 675 1:CAS:528:DC%2BD1cXmvVCisrY%3D 10.1038/nbt1407
9. McEwen I, Mulloy B, Hellwig E, kozerski L, Beyer T, Holzgrabe U, Rodomonte A, Wanko R, Spieser JM. Determination of oversulphated chondroitin sulphate and dermatan sulphate in unfractioned heparin by 1H NMR. Pharmeuropa Bio 2008:31-39
10. V Ruiz-Calero J Suarina MT Galceran S Hernandez-Cassou L Puignou 2002 Proton nuclear magnetic resonance characterization of glycosaminoglycans using chemometric techniques Analyst 127 407 415 1:CAS:528:DC%2BD38Xhs1aks70%3D 10.1039/b110558m
11. GA Neville F Mori KR Holme AS Perlin 1988 Monitoring the purity of pharmaceutical heparin preparations by High-Field ' H-Nuclear magnetic resonance spectroscopy J Pharm Sci 78 2 101 104 10.1002/jps.2600780205
12. V Ruiz-Calero J Saurina MT Galceran S Hernandez-Cassou L Puignou 2000 Potentiality of proton nuclear magnetic resonance and multivariate calibration methods for the determination of dermatan sulfate contamination in heparin samples Analyst 125 933 938 1:CAS:528:DC%2BD3cXivFemtLc%3D 10.1039/b000768o
13. Wise BM. http://www.eigenvector.com
14. Vandeginste BGM, Massart DL, Buydens LMC, De jong S, Lewi PJ, Smeyers-verbeke J. Handbook of chemometrics and qualimetrics. Part A and B 1998: Elsevier
15. KR Holme AS Perlin 1989 Nuclear magnetic resonance spectra of heparin in admixture with dermatan sulfate and other glycosaminoglycans. 2D spectra of chondroitin sulfates Carbohydr Res 186 2 301 312 1:CAS:528:DyaL1MXhsFSisLk%3D 10.1016/0008-6215(89)84044-3